Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : The Stock for 1999(Polymedica)PLMD(Medical Supply Co.) -- Ignore unavailable to you. Want to Upgrade?

To: Kevin Podsiadlik who wrote (3360)	8/22/2001 2:17:57 AM
From: Apakhabar	Read Replies (1) \| Respond to of 3414

It's not over until the FBI makes some sort of announcement and some basic questions get answered: 1. When will PLMD resume operations? 2. Will they get kicked out of Medicare? 3. Will senior officers get indicted? At this point the longs can only pray for a big fine and some minor indictments as long as the company is allowed to resume operations and stay with Medicare. There's a very real chance that the company is going to be booted out of the Medicare program. That will destroy the stock for good. I can't believe that 85 agents will raid a business that isn't guilty of something more serious than offenses that merit only fines. But we'll find out in time. As for the long-time longs here you have my sympathies.

To: Kevin Podsiadlik who wrote (3360)	8/22/2001 12:16:27 PM
From: Mike E.	Read Replies (1) \| Respond to of 3414

Search Warrants Executed by FBI At PolyMedica Subsidiaries in Florida; Normal Operations Resumed Today Business Editors WOBURN, Mass.--(BUSINESS WIRE)--Aug. 22, 2001--PolyMedica Corporation (NNM: PLMD) reported that agents from the Federal Bureau of Investigation executed search warrants yesterday at facilities of PolyMedica's subsidiaries Liberty Medical Supply and Liberty Home Pharmacy in Florida and served a grand jury subpoena on PolyMedica. The FBI copied extensive records of the Company. The Company does not know the extent of the investigation. Both subsidiaries resumed normal operations this morning. Trading in PolyMedica's stock was halted yesterday pending dissemination of this news. PolyMedica and Liberty are continuing to cooperate fully with the investigation. About PolyMedica (www.polymedica.com) PolyMedica is a rapidly growing national medical products and services company. The Company is best known through its Liberty Medical brand name and innovative direct-to-consumer television advertising to seniors with diabetes. Building on its technology-based operating platform and compliance management focus, PolyMedica has expanded its chronic disease business into the respiratory market. In addition, the Company's AZO line of products addresses female urinary tract discomfort, where it is the market leader, as well as symptoms of menopause and incontinence. PolyMedica is included in the Russell 2000 and S&P Small Cap 600 indices. This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from those anticipated. Such risks and uncertainties include, but are not limited to, outcomes of pending government inquiries and investigations, continued compliance with government regulations, unanticipated regulatory changes, changes in Medicare reimbursement, fluctuations in customer demand, management of rapid growth, intensity of competition from other healthcare product vendors, timing and acceptance of new product introductions, general economic conditions and regulatory changes, as well as other especially relevant risks detailed in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the period ended March 31, 2001 and its Quarterly Report on Form 10-Q for the period ended June 30, 2001, and the information set forth herein should be read in light of such risks. The Company assumes no obligation to update the information contained in this press release. --30--es/ny* mw/ny CONTACT: PolyMedica Corporation, Woburn Eric G. Walters, 781/933-2020 or VMW Corporate & Investor Relations, New York Sylvia A. Dresner, 212/616-6161 info@vmwcom.com KEYWORD: MASSACHUSETTS FLORIDA INDUSTRY KEYWORD: BIOTECHNOLOGY MEDICAL MEDICAL DEVICES PHARMACEUTICAL SOURCE: PolyMedica Corporation Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. URL: businesswire.com